RINVOQ 15 mg prolonged-release tablets

Company
AbbVie Limited
Active Ingredient
Dosage Form
Prolonged-release tablet
Legal Category
A - prescription, may not be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/19/1404/001 15 milligram(s) L04AF03 Prolonged-release tablet
Licence number
EU/1/19/1404/001
Strength
15 milligram(s)
ATC Code
L04AF03
Dosage Form
Prolonged-release tablet

AbbVie Limited

Citywest Business Campus, Dublin 24, Ireland